drugset / Trial / NCT02895724
Hyperbaric Oxygen Therapy to Reduce Lymphedema After Breast Cancer -an Explorative Clinical Trial
Phase 2
Unknown
20 enrolled
Danish Cancer Society
Herlev Hospital · collabRigshospitalet, Denmark · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to examine if pressurechamber treatment (HBOT) can reduce early stages of breast cancer related lymphedema, and to explore the mechanisms involved in the disease progress.
Timeline
- Start
- 2016-09
- Primary completion
- 2018-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxygen | Other / unclassified | 100 % | Inhaled |